EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 26-Apr-2025 04:08 ET (26-Apr-2025 08:08 GMT/UTC)

Maternal childhood trauma may lead to early metabolic changes in male children

Fundação de Amparo à Pesquisa do Estado de São Paulo
Peer-Reviewed Publication

This is the finding of a study that followed 352 pairs of newborns and their mothers in the cities of Guarulhos and São Paulo (Brazil). Changes observed in the first two months of life may increase future risk of obesity and diabetes.

Journal: Scientific Reports
Funder: Fundação de Amparo à Pesquisa do Estado de São Paulo

How an antimalarial drug could help fix genetic diseases

University of Groningen
Peer-Reviewed Publication

The antimalarial drug mefloquine could help treat genetic diseases such as cystic fibrosis, Duchenne muscular dystrophy and some cancers.

Journal: Proceedings of the National Academy of Sciences

Researchers crack the code of cell movement

St. Jude Children's Research Hospital
Peer-Reviewed Publication

Scientists at St. Jude Children’s Research Hospital and the Medical College of Wisconsin have discovered how chemokines and G protein-coupled receptors selectively bind each other to control how cells move.

Journal: Cell

MSK Research Highlights, April 23, 2025

Memorial Sloan Kettering Cancer Center
Peer-Reviewed Publication

New research from Memorial Sloan Kettering Cancer Center (MSK) identifies a rare cell population responsible for AML persistence and resistance to therapy; sheds new light on early brain development; and investigates how other health conditions can increase cancer risk in midlife. MSK clinical trials also supported the recent approval of the targeted drug larotrectinib by the FDA.

Childhood exposure to bacterial toxin may be triggering colorectal cancer epidemic among the young

University of California - San Diego
Peer-Reviewed Publication

An international team led by the University of California San Diego has identified a potential microbial culprit behind the alarming rise in early-onset colorectal cancer: a bacterial toxin called colibactin. Scientists report that exposure to colibactin in early childhood imprints a distinct genetic signature on the DNA of colon cells—one that may increase the risk of developing colorectal cancer before the age of 50.

Journal: Nature
Funder: Cancer Research UK, NIH/National Institutes of Health, Wellcome Trust

How bacteria in our aging guts can elevate risk of leukemia and perhaps more

Cincinnati Children's Hospital Medical Center
Peer-Reviewed Publication

"This study significantly advances our understanding about how blood cancers develop and progress, especially in older adults," says corresponding author Dr. Dan Starczynowski, Cincinnati Children's.

Journal: Nature
Funder: NIH/National Institutes of Health, NIH/National Institute of Environmental Health Sciences

Remembering the cold: scientists discover how memories control metabolism

Trinity College Dublin
Peer-Reviewed Publication

New multidisciplinary research led by Prof. Tomás Ryan from Trinity College Dublin shows that the brain forms memories of cold experiences and uses them to control our metabolism. This newly published study is the first to show that cold memories form in the brain – and map out how they subsequently drive thermoregulation.

The discovery may have important applications in therapies designed to treat a range of disorders – from obesity to cancer – in which thermoregulation and metabolism (or a lack of control in this area) plays a role, as well as opening the door to more fundamental research, which could help us better understand how memories impact our behaviour and emotions.

Journal: Nature
Funder: Taighde Eireann -- Research Ireland, European Research Council, Air Force Office of Scientific Research Cognitive and Computational Neuroscience program

Patient with rare cancer first in U.S. to be treated with groundbreaking, highly accurate proton beam arc therapy

Corewell Health
Peer-Reviewed Publication

For many cancer patients, side effects from radiation can be debilitating. But a new way of delivering radiation treatment has proven effective at eliminating a hard-to-treat cancer with the only side effect being light skin discoloration, even nine months after treatment. This new treatment, step-and-shoot proton arc therapy, is the first to be used by physicians and scientists to treat a patient at Corewell Health William Beaumont University Hospital in Royal Oak, Michigan.

Journal: International Journal of Particle Therapy
Meeting: International Symposium on Proton Therapy

Rathmell named CEO of Ohio State’s James Cancer Hospital and Solove Research Institute

Ohio State University Wexner Medical Center
Business Announcement

Following a comprehensive national search, W. Kimryn Rathmell, MD, PhD, former director of the National Cancer Institute (NCI), has accepted the role as CEO of The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James). Pending approval by the university Board of Trustees, Rathmell will start on May 27.

Statin use may improve survival in patients with some blood cancers

American Society of Hematology
Peer-Reviewed Publication

(WASHINGTON—April 23, 2025) — Patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who were taking cholesterol-lowering statin medications at the start of their cancer treatment had a 61% lower risk of dying from their cancer compared to similar patients who were not taking statins, according to a study published today in the journal Blood Advances.

Journal: Blood Advances

3
4
5
6
7